Global Medical REIT (NYSE:XRN) COO Purchases $495,855.00 in Stock

Global Medical REIT Inc. (NYSE:XRN) COO Aaron Robert Roseth purchased 13,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 12th. The stock was bought at an average price of $36.73 per share, with a total value of $495,855.00. Following the transaction, the chief operating officer directly owned 13,500 shares in the company, valued at $495,855. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Global Medical REIT Trading Up 0.7%

Shares of XRN traded up $0.25 during midday trading on Thursday, hitting $36.52. The stock had a trading volume of 100,235 shares, compared to its average volume of 89,274. The company has a current ratio of 0.68, a quick ratio of 0.68 and a debt-to-equity ratio of 1.68. Global Medical REIT Inc. has a fifty-two week low of $29.05 and a fifty-two week high of $39.93. The business has a 50-day simple moving average of $36.59 and a two-hundred day simple moving average of $35.80. The firm has a market cap of $483.50 million, a P/E ratio of 9.82 and a beta of 1.09.

Global Medical REIT (NYSE:XRN) last released its quarterly earnings data on Wednesday, August 5th. The company reported $4.78 EPS for the quarter, topping analysts’ consensus estimates of $0.83 by $3.95. Global Medical REIT had a return on equity of 13.74% and a net margin of 36.82%.The firm had revenue of $39.75 million for the quarter. As a group, equities analysts forecast that Global Medical REIT Inc. will post 3.06 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. AQR Capital Management LLC increased its stake in shares of Global Medical REIT by 9.5% in the 1st quarter. AQR Capital Management LLC now owns 58,538 shares of the company’s stock valued at $512,000 after buying an additional 5,062 shares during the period. Jones Financial Companies Lllp lifted its stake in shares of Global Medical REIT by 23,920.0% in the 1st quarter. Jones Financial Companies Lllp now owns 24,020 shares of the company’s stock valued at $210,000 after purchasing an additional 23,920 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of Global Medical REIT by 13.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 388,605 shares of the company’s stock worth $3,400,000 after purchasing an additional 45,243 shares during the last quarter. Strs Ohio acquired a new stake in shares of Global Medical REIT during the first quarter worth $95,000. Finally, Envestnet Asset Management Inc. lifted its stake in Global Medical REIT by 39.5% in the second quarter. Envestnet Asset Management Inc. now owns 26,617 shares of the company’s stock valued at $184,000 after buying an additional 7,536 shares during the period. 57.52% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

XRN has been the subject of a number of research reports. Citizens Jmp increased their price target on shares of Global Medical REIT from $40.00 to $42.00 and gave the company a “market outperform” rating in a report on Tuesday, May 26th. Compass Point reissued a “neutral” rating and set a $38.00 price objective (down from $50.00) on shares of Global Medical REIT in a report on Thursday, May 7th. Zacks Research upgraded Global Medical REIT to a “hold” rating in a research report on Wednesday, July 22nd. Weiss Ratings lowered Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, July 30th. Finally, Raymond James Financial initiated coverage on Global Medical REIT in a research report on Wednesday, June 17th. They issued a “market perform” rating for the company. Two investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $40.25.

Key Headlines Impacting Global Medical REIT

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: Director Charles Fitzgerald purchased 14,000 shares for approximately $500,920 at an average price of $35.78, increasing his direct ownership by 11.21%. This followed his purchase of another 27,600 shares, worth about $991,944, on August 10. SEC insider purchase filing
• Positive Sentiment: CEO Mark Okey Decker Jr. bought 8,000 shares for $287,040 on August 10 and an additional 550 shares for $19,800 on August 11. The purchases increased his holdings by 13.38% and 0.81%, respectively, signaling management confidence in the company’s valuation and outlook. CEO insider buying report
• Positive Sentiment: Global Medical REIT reported quarterly earnings per share of $4.78, exceeding the $0.83 consensus estimate by $3.95, with revenue of $39.75 million. The company posted a 36.82% net margin and 13.74% return on equity, while analysts expect full-year EPS of $3.06.
• Positive Sentiment: Some analysts remain constructive: Citizens JMP raised its price target to $42 from $40 and maintained an outperform rating. The average analyst price target is $40.25, above the recent trading level.
• Neutral Sentiment: Institutional ownership remains substantial at 57.52%. Invesco increased its position, and several other investment firms recently initiated or expanded holdings, providing some support from professional investors.
• Negative Sentiment: Analyst sentiment is mixed, with an overall “Hold” rating. Compass Point cut its price target to $38 from $50, Wall Street Zen downgraded the stock to “Sell,” and Raymond James initiated coverage at “Market Perform.”
• Negative Sentiment: The REIT carries meaningful leverage, with a debt-to-equity ratio of 1.68 and current and quick ratios of 0.68, factors that could limit financial flexibility if interest rates or property-market conditions worsen.

Global Medical REIT Company Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.